INSP icon

Inspire Medical Systems

151.25 USD
-1.54
1.01%
At close May 9, 4:00 PM EDT
Pre-market
147.00
-4.25
2.81%
1 day
-1.01%
5 days
-4.81%
1 month
-1.66%
3 months
-16.43%
6 months
-25.14%
Year to date
-20.05%
1 year
-13.26%
5 years
115.00%
10 years
505.48%
 

About: Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Employees: 1,246

0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 7 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

39% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 44

33% more funds holding in top 10

Funds holding in top 10: 6 [Q3] → 8 (+2) [Q4]

4% more funds holding

Funds holding: 341 [Q3] → 353 (+12) [Q4]

0.64% more ownership

Funds ownership: 110.78% [Q3] → 111.43% (+0.64%) [Q4]

7% less repeat investments, than reductions

Existing positions increased: 116 | Existing positions reduced: 125

11% less capital invested

Capital invested by funds: $6.97B [Q3] → $6.2B (-$769M) [Q4]

26% less call options, than puts

Call options by funds: $54.8M | Put options by funds: $73.8M

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$174
15%
upside
Avg. target
$202
33%
upside
High target
$236
56%
upside

7 analyst ratings

positive
71%
neutral
29%
negative
0%
Morgan Stanley
Kallum Titchmarsh
67% 1-year accuracy
2 / 3 met price target
32%upside
$200
Overweight
Maintained
6 May 2025
JP Morgan
Robbie Marcus
50% 1-year accuracy
10 / 20 met price target
29%upside
$195
Overweight
Maintained
6 May 2025
Wells Fargo
Larry Biegelsen
32% 1-year accuracy
13 / 41 met price target
15%upside
$174
Equal-Weight
Maintained
6 May 2025
Baird
Mike Polark
58% 1-year accuracy
7 / 12 met price target
56%upside
$236
Outperform
Maintained
6 May 2025
Stifel
Jonathan Block
25% 1-year accuracy
5 / 20 met price target
16%upside
$175
Hold
Maintained
21 Apr 2025

Financial journalist opinion

Based on 9 articles about INSP published over the past 30 days

Neutral
GlobeNewsWire
4 days ago
Dr. Jose Jacob Scholarship for Future Doctors Opens Nationwide: A Timely Opportunity to Inspire Medical Students to Address Real-World Healthcare Challenges
OCALA, Fla., May 07, 2025 (GLOBE NEWSWIRE) -- The Dr. Jose Jacob Scholarship for Future Doctors is now officially open for applications, offering a one-time award of $1,000 to undergraduate students across the United States who are committed to pursuing a career in medicine.
Dr. Jose Jacob Scholarship for Future Doctors Opens Nationwide: A Timely Opportunity to Inspire Medical Students to Address Real-World Healthcare Challenges
Positive
Zacks Investment Research
4 days ago
All You Need to Know About Inspire (INSP) Rating Upgrade to Buy
Inspire (INSP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
All You Need to Know About Inspire (INSP) Rating Upgrade to Buy
Positive
Zacks Investment Research
4 days ago
Wall Street Analysts Predict a 39.04% Upside in Inspire (INSP): Here's What You Should Know
The consensus price target hints at a 39% upside potential for Inspire (INSP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Wall Street Analysts Predict a 39.04% Upside in Inspire (INSP): Here's What You Should Know
Positive
Zacks Investment Research
5 days ago
INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts
Inspire Medical's first-quarter 2025 performance reflects increased market penetration in existing centers and expansion into new territories and centers, along with strong domestic results.
INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts
Neutral
Seeking Alpha
6 days ago
Inspire Medical Systems, Inc. (INSP) Q1 2025 Earnings Call Transcript
Inspire Medical Systems, Inc. (NYSE:INSP ) Q1 2025 Results Conference Call May 5, 2025 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Kallum Titchmarsh - Morgan Stanley David Rescott - Baird Michael Sarcone - Jefferies Shagun Singh - RBC Chris Pasquale - Nephron Research Larry Biegelsen - Wells Fargo Anthony Petrone - Mizuho Financial Group Jon Block - Stifel Brett Fishbin - KeyBanc Capital Markets Michael Polark - Wolfe Research Travis Steed - Bank of America Securities Danielle Antalffy - UBS Robbie Marcus - JPM Adam Maeder - Piper Sandler Richard Newitter - Truist Operator Good afternoon. My name is Dilem and I'll be your conference operator today.
Inspire Medical Systems, Inc. (INSP) Q1 2025 Earnings Call Transcript
Positive
Zacks Investment Research
6 days ago
Inspire Medical Systems (INSP) Surpasses Q1 Earnings and Revenue Estimates
Inspire Medical Systems (INSP) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of a loss of $0.23 per share. This compares to loss of $0.34 per share a year ago.
Inspire Medical Systems (INSP) Surpasses Q1 Earnings and Revenue Estimates
Neutral
GlobeNewsWire
6 days ago
Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook
Inspire Reports Year-over-Year Revenue Growth of 23% and Earnings per Share of $0.10 in the First Quarter Inspire Reports Year-over-Year Revenue Growth of 23% and Earnings per Share of $0.10 in the First Quarter
Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook
Neutral
GlobeNewsWire
1 week ago
Inspire Medical Systems, Inc. to Present at the BofA Securities 2025 Health Care Conference
MINNEAPOLIS, April 29, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025. Inspire is scheduled to present at 2:20 p.m.
Inspire Medical Systems, Inc. to Present at the BofA Securities 2025 Health Care Conference
Neutral
GlobeNewsWire
2 weeks ago
Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D.
MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that two leading physicians in the field of sleep medicine and sleep surgery, Paul T. Hoff, M.D., M.S., an otolaryngologist, and Ruchir P. Patel, M.D., F.A.C.P., a sleep medicine specialist, will join Inspire in Vice President, Senior Medical Director roles, effective April 21 and June 2 respectively.
Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D.
Neutral
GlobeNewsWire
1 month ago
Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025
MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2025 after the close of trading on Monday, May 5. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m.
Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025
Charts implemented using Lightweight Charts™